Microsomal Prostaglandin E Synthase 1 Deletion Retards Renal Disease Progression But Exacerbates Anemia in Mice With Renal Mass Reduction-Reference-Cited by-同舟云学术

Microsomal Prostaglandin E Synthase 1 Deletion Retards Renal Disease Progression But Exacerbates Anemia in Mice With Renal Mass Reduction

Published:2012-01 Issue:1 Volume:59 Page:122-128
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Jia Zhanjun¹,Wang Haiping¹,Yang Tianxin¹

Affiliation:

1. From the Department of Internal Medicine (Z.J., H.W., T.Y.), University of Utah and Veterans Affairs Medical Center, Salt Lake City, UT; Center for Hypertension (T.Y.), Sun Yat-sen University School of Medicine, Guangzhou, China.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference36 articles.

1. Epithelial to Mesenchymal Transition in Renal Fibrogenesis: Pathologic Significance, Molecular Mechanism, and Therapeutic Intervention

2. Prostaglandin E Synthase: A Novel Drug Target for Inflammation and Cancer

3. Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target

4. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

5. Deletion of Microsomal Prostaglandin E Synthase-1 Increases Sensitivity to Salt Loading and Angiotensin II Infusion

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease;Journal of the American Heart Association;2024-02-20

2. Targeting mPGES-2 to protect against acute kidney injury via inhibition of ferroptosis dependent on p53;Cell Death & Disease;2023-10-31

3. Prostaglandin E2 receptors as therapeutic targets in renal fibrosis;Kidney Research and Clinical Practice;2022-01-31

4. Alternatives to animal testing: concepts, state of art, and regulations;Biomedical Product and Materials Evaluation;2022

5. (Pro)renin receptor antagonist PRO20 attenuates nephrectomy‐induced nephropathy in rats via inhibition of intrarenal RAS and Wnt/β‐catenin signaling;Physiological Reports;2021-05-31